The role of bone marrow-derived cells in fibrosis.
There is a growing realization that bone marrow-derived cells (BMDCs) are a potential therapy for many diseases including ischemic heart disease, arterial stenosis and osteogenesis imperfecta. On the other hand, the fact that BMDCs may also contribute to fibrosis in many solid organs as well as to fibrosis surrounding tumours suggests that BMDCs are also involved in disease progression. This review focuses on the contribution of bone marrow cells to organ and tumour fibrosis, noting the utility of BMDCs as a potential new portal through which to direct anti-tumour therapies. Conversely, bone marrow cell therapy has been claimed to reduce fibrosis in some organs, highlighting a seemingly beneficial as opposed to a detrimental effect of BMDCs on organ fibrosis.
Lin
Wey-Ran
WR
Diabetes and Molecular Medicine, Institute of Cell and Molecular Science, Queen Mary University of London, London, UK.
Brittan
Mairi
M
Alison
Malcolm R
MR
D000818:Animals; D001854:Bone Marrow Cells / Q000473:pathology*; D005347:Fibroblasts / Q000166:cytology; D005355:Fibrosis; D006412:Hematopoietic Stem Cells / Q000166:cytology; D008648:Mesoderm / Q000166:cytology; D017154:Stromal Cells / Q000166:cytology